How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,427 results for

Congenital Heart Disease Imaging in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death

a perfusion system and the experiences, preferences, and values of people with heart failure and family members of organ donors. BACKGROUND Health Condition Heart failure can occur as a result of congenital heart defects, coronary heart disease, and cardiomyopathy of various aetiologies, among other causes. 1 There were 419,551 incident cases of heart failure in Ontario over the period 1997 to 2007. 2 Interventions to manage end- stage heart failure include medication and mechanical circulatory support (...) as a result of congenital heart defects (problems with the structure of the heart that are present at birth), coronary heart disease (a narrowing of the heart’s coronary arteries), or any number of diseases that cause the heart muscle to become thick or rigid or to harden. Interventions to manage end-stage heart failure include medications and mechanical circulatory support; however, heart transplantation is the most effective treatment for some people with end-stage heart failure. It is considered

2020 Health Quality Ontario

122. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease

to ASCAD, other coronary conditions such as coronary vasospasm, myocardial bridging, and coronary dissection, as well as infection such as Kawasaki disease, vasculitis, and cardiac transplant vasculopathy, may also cause acute cardiac events during exercise. The present section makes recommendations on how to evaluate patients with disease of the coronary arteries and make appropriate recommendations for athletic competition. Anomalous coronary arteries are considered in the Task Force 4 report. We (...) is greater in those who have had a previous acute cardiac syndrome and lower in those whose ASCAD is clinically silent and was diagnosed by such techniques as coronary artery calcification scanning or computed tomography angiography. (2) The risk of an acute exertion-related cardiac event increases with increasing extent of coronary artery disease, reduced left ventricular systolic function, the presence and extent of ischemia, and increased electrical instability. Unstable or “vulnerable” plaques

2015 American Heart Association

123. Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease

undergoing cardiac surgery Criteria Inclusion Criteria: Pre-operative diagnosis of cyanotic congenital heart disease Undergoing any form of cardiac surgery Informed consent was given by the caregiver/parent Exclusion Criteria: Premature infants <35 weeks corrected age who will be cared for in the neonatal ICU postoperatively Congenital lactic acidosis syndromes Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact (...) by (Responsible Party): Judith Wong Ju-Ming, KK Women's and Children's Hospital Study Details Study Description Go to Brief Summary: We are conducting a prospective cohort study of 20 children with cyanotic congenital heart disease who are admitted for cardiac surgery. We will record cerebral and somatic near infrared spectroscopy (NIRS) at two sites - forehead and flank regions using the Covidien INVOS™ 5100C Cerebral / Somatic Oximeter. The monitoring will begin one hour pre-operatively (baseline

2015 Clinical Trials

124. Effects of High-intensity Interval Training on Exercise Capacity in Patients With Grown-up Congenital Heart Disease

markers for heart failure as well as occurrence of irregular fast heart beats will be assessed. Condition or disease Intervention/treatment Phase Congenital Heart Defects Procedure: HIIT Other: MICE Not Applicable Detailed Description: Background Adults with congenital heart disease have long been recommended to refrain from physical exercise. Therefore, they often have significant reduction in exercise capacity. Only recently, regular exercise has been shown to be safe and is nowadays recommended (...) and important exercise modality in cardiac rehabilitation centers all over Europe for stable cardiac patients with left ventricular (LV) dysfunction. However, its safety and efficacy has not yet been tested in adults with congenital heart disease and to date there are no studies who have evaluated whether short term peaks of pulmonary artery or systemic pressure during bouts of 4 min of high-intensity exercise negatively affects the subpulmonary or systemic ventricle in GUCH patients. The investigators

2015 Clinical Trials

125. NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease

tachyarrhythmia in adult CHD patients. Primary endpoint assessment will be performed with a per protocol analysis, and demonstrated as Kaplan Meyer estimates of event free survival and event rates per year. Condition or disease Congenital Heart Defects Atrial Fibrillation Ectopic Atrial Tachycardia Study Design Go to Layout table for study information Study Type : Observational [Patient Registry] Estimated Enrollment : 300 participants Observational Model: Cohort Time Perspective: Prospective Target Follow-Up (...) Posted : October 10, 2016 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Collaborator: The Interuniversity Cardiology Institute of the Netherlands Information provided by (Responsible Party): Berto J Bouma, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Study Details Study Description Go to Brief Summary: Rationale: Adult patients with congenital heart disease (CHD) with atrial tachyarrhythmias need to be anticoagulated. It is not known whether non

2015 Clinical Trials

126. T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease

. Condition or disease Intervention/treatment Phase Cardiomyopathy Other: Cardiac magnetic resonance sequence T1 mapping Not Applicable Detailed Description: A better understanding of the mechanisms by which the heart muscle fails in pediatric heart disease may result in novel therapies directed at preventing rather than treating ventricular failure. The most likely mediator candidate for cardiac demise in congenital heart disease as well as the cardiomyopathies is diffuse myocardial fibrosis and non (...) Posted : April 16, 2015 Sponsor: The Hospital for Sick Children Information provided by (Responsible Party): Lars Grosse-Wortmann, The Hospital for Sick Children Study Details Study Description Go to Brief Summary: Diffuse fibrosis (or scarring) of the heart muscle is found in a variety of congenital heart diseases and in cardiomyopathies (heart muscle disease), and is considered a mediator of decreased cardiac function. The detection and quantification of diffuse myocardial fibrosis has recently

2015 Clinical Trials

127. Post-interventional three-dimensional dark blood MRI in the adult with congenital heart disease. (Abstract)

Post-interventional three-dimensional dark blood MRI in the adult with congenital heart disease. Investigate a novel three-dimensional (3D) turbo spin echo (TSE) magnetic resonance imaging (MRI) sequence to assess stented segments in adults with congenital heart disease (CHD) after transcatheter intervention.Adults with CHD referred for computed tomography (CT) after transcatheter intervention underwent MR exam with a 3D respiratory gated TSE sequence. Data obtained at the time of the study

2012 International journal of cardiology

128. Routine preoperative testing in adults undergoing elective non-cardiothoracic surgery

predictors included mild stable chronic angina, a history of known myocardial infarction or Q waves on a preoperative electrocardiogram (ECG), compensated or prior congestive heart failure, or a history of diabetes mellitus (insulin or noninsulin dependent). Patients with high-risk clinical predictors such as unstable coronary syndromes, severe valvular disease, or decompensated congestive heart failure were excluded. Of 46 patients randomized to preoperative stress testing, 41 (89%) patients underwent (...) preoperative testing KCE Report 280 3.12 GLYCATED HAEMOGLOBIN TEST (HBA1C) 49 3.12.1 Introduction 49 3.12.2 HbA1c in diabetes 49 3.12.3 HbA1c in undiagnosed diabetes 51 3.13 LIVER FUNCTION TESTS 52 3.14 URINALYSIS 53 3.14.1 Introduction 53 3.14.2 Urine culture 53 3.14.3 Biochemical and other urinary tests 55 3.15 NON-INVASIVE CARDIAC STRESS IMAGING 56 3.15.1 Stress echocardiography 56 3.15.2 Myocardial scintigraphy 58 3.16 CORONARY CT ANGIOGRAPHY 60 3.16.1 Introduction 60 3.16.2 Evidence for clinical

2017 Belgian Health Care Knowledge Centre

129. Normal values for myocardial deformation within the right heart measured by feature-tracking cardiovascular magnetic resonance imaging. Full Text available with Trip Pro

Normal values for myocardial deformation within the right heart measured by feature-tracking cardiovascular magnetic resonance imaging. Reproducible and repeatable assessment of right heart function is vital for monitoring congenital and acquired heart disease. There is increasing evidence for the additional value of myocardial deformation (strain and strain rate) in determining prognosis. This study aims to determine the reproducibility of deformation analyses in the right heart using (...) cardiovascular magnetic resonance feature tracking (FT-CMR); and to establish normal ranges within an adult population.A cohort of 100 healthy subjects containing 10 males and 10 females from each decade of life between the ages of 20 and 70 without known congenital or acquired cardiovascular disease, hypertension, diabetes, dyslipidaemia or renal, hepatic, haematologic and systemic inflammatory disorders underwent FT-CMR assessment of right ventricular (RV) and right atrial (RA) myocardial strain and strain

2017 International journal of cardiology

130. Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires

Intervention/treatment Phase Pulmonary Artery Hypertension Congenital Heart Disease Structural Heart Disease Procedure: MRI Right Heart guidewire catheterization Phase 1 Phase 2 Detailed Description: Heart catheterization is a minimally invasive procedure to measure pressure into specific heart cavities. Heart catheterization usually uses X-ray guidance, which involves radiation exposure, and which fails to visualize soft tissue. For several years, real-time magnetic resonance imaging (MRI) fluoroscopy has (...) on a table that slides in and out of the MRI scanner as it makes pictures. Participants will get earplugs for the loud knocking noise. They can talk on an intercom. They will be inside the scanner for up to 2 hours. They can ask to stop at any time. For right heart catheterization, catheters will be inserted through the tubes already in place. The catheters are guided by MRI fluoroscopy into the chambers of the heart and vessels. The guidewire will help position the catheter. Condition or disease

2017 Clinical Trials

131. ISHLT Consensus Statement on Donor Organ Acceptability and Management in Pediatric Heart Transplantation Full Text available with Trip Pro

. Mortality varies by several factors including recipient age, diagnosis, and acuity of illness. Approximately 25% of infants in the US die waiting for a heart, compared with around 15% for children and adolescents. x 8 Mah, D, Singh, TP, Thiagarajan, RR et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant . 2009 ; 28 : 1292–1298 Waitlist mortality for patients with congenital heart disease (CHD, 22%) x 1 Almond, CSD, Thiagarajan, RR (...) , FRCPC b , x Ryan R. Davies Affiliations Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Children's Medical Center, Dallas, Texas , MD c , x Oliver Miera Affiliations Department of Congenital Heart Disease/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany , MD d , x Gretchen Chapman Affiliations Carnegie Mellon University, Pittsburgh, Pennsylvania , PhD e , x Jennifer Conway Affiliations Department of Pediatrics, Division

2020 International Society for Heart and Lung Transplantation

132. Coronary Atherosclerosis Disease Early Identification and Risk Stratification by Noninvasive Imaging

Criteria: suspected of coronary heart disease, coronary CTA has been completed. age > 18 years old. have biochemical test results. signed informed consent. Exclusion Criteria: malignant tumor, severe liver and kidney diseases. combination of cardiomyopathy, valvular disease, congenital heart disease, a variety of reasons the left cardiac insufficiency. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study (...) adverse cardiac events (MACE).The investigator aim to evaluate the prognostic value of CTA, risk factors and bio-markers for MACE. Condition or disease Coronary Artery Disease Detailed Description: The investigator prospectively enroll 30,000 outpatients who were suspected of coronary artery disease (CAD) and underwent cardiac computed tomography (CT). Cardiac CT was assessed for coronary artery calcification score (CACS) and the extent, the location, the stenosis severity, and the composition

2016 Clinical Trials

133. Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging

Sickle Cell Disease Acute Chest Syndrome Pulmonary Syndrome Pneumonia Additional relevant MeSH terms: Layout table for MeSH terms Syndrome Anemia, Sickle Cell Acute Chest Syndrome Disease Pathologic Processes Anemia, Hemolytic, Congenital Anemia, Hemolytic Anemia Hematologic Diseases Hemoglobinopathies Genetic Diseases, Inborn Lung Diseases Respiratory Tract Diseases Respiration Disorders (...) Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2018 Clinical Trials

134. Procedure Sedation With Dexmedetomidine in Children With Autism Spectrum Disorders During Magnetic Resonance Imaging

or hypersensitive reaction to dexmedetomidine Organ dysfunction, and significant developmental delays or behavior problems Cardiac arrhythmia Known. acyanotic congenital heart disease or children after cardiac interventional procedures for follow-up examination Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study (...) interests, and repetitive behaviors.The children with ASD has been shown different drug responses from the normal population of children. The children with ASD maybe more prone to elevate anxiety and the difficult of sedation during MRI scanning.The purpose of this investigation was to compare the effectiveness of dexmedetomidine sedation in children with and without ASD undergoing MRI scanning. Condition or disease Intervention/treatment Autism Spectrum Disorder Drug: Dexmedetomidine Detailed

2018 Clinical Trials

135. Guideline for the management of adults with Systemic Lupus Erythematosus Full Text available with Trip Pro

Guideline for the management of adults with Systemic Lupus Erythematosus We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults | Rheumatology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input (...) Article Navigation Close mobile search navigation Article navigation January 2018 Article Contents Article Navigation The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Caroline Gordon Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham,Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust,Rheumatology Department, University

2017 British Society for Rheumatology

136. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

With Preserved Ejection Fraction e51 9.3. Chronic Kidney Disease e51 9.3.1. Hypertension After Renal Transplantation e53 9.4. Cerebrovascular Disease e53 9.4.1. Acute Intracerebral Hemorrhage e54 9.4.2. Acute Ischemic Stroke e54 9.4.3. Secondary Stroke Prevention e56 9.5. Peripheral Artery Disease e57 9.6. Diabetes Mellitus e58 9.7. Metabolic Syndrome e59 9.8. Atrial Fibrillation e59 9.9. Valvular Heart Disease e60 9.10. Aortic Disease e60 10. Special Patient Groups e60 10.1. Race and Ethnicity e60 10.1.1 (...) Society 2014 Atrial fibrillation AHA/ACC/HRS 2014 Valvular heart disease ACC/AHA 2017 Assessment of cardiovascular risk ACC/AHA 2013 Hypertension in pregnancy ACOG 2013 Heart failure ACC/AHA 2017 2013 Lifestyle management to reduce cardiovascular risk AHA/ACC 2013 Management of arterial hypertension ESH/ESC 2013 Management of overweight and obesity in adults AHA/ACC/TOS 2013 ST-elevation myocardial infarction ACC/AHA 2013 Treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk

2017 American Heart Association

137. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary Full Text available with Trip Pro

. Stable Ischemic Heart Disease 1291 9.2. Heart Failure 1292 9.2.1. Heart Failure With Reduced Ejection Fraction 1292 9.2.2. Heart Failure With Preserved Ejection Fraction 1292 9.3. Chronic Kidney Disease 1292 9.3.1. Hypertension After Renal Transplantation 1292 9.4. Cerebrovascular Disease 1293 9.4.1. Acute Intracerebral Hemorrhage 1293 9.4.2. Acute Ischemic Stroke 1293 9.4.3. Secondary Stroke Prevention 1294 9.5. Peripheral Artery Disease 1295 9.6. Diabetes Mellitus 1295 9.7. Metabolic Syndrome 1296 (...) of overweight and obesity in adults AHA/ACC/TOS 2013 ST-elevation myocardial infarction ACC/AHA 2013 Treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults ACC/AHA 2013 Cardiovascular diseases during pregnancy ESC 2011 Effectiveness-based guidelines for the prevention of cardiovascular disease in women AHA/ACC 2011 Secondary prevention and risk-reduction therapy for patients with coronary and other atherosclerotic vascular disease AHA/ACC 2011 Assessment of cardiovascular

2017 American Heart Association

138. Valvular Heart Disease

entities having participated in the development of this document: Associations: European Association of Echocardiography (EAE), European Association of Percutaneous Cardiovascular Interventions (EAPCI), Heart Failure Association (HFA) Working Groups: Acute Cardiac Care, Cardiovascular Surgery, Valvular Heart Disease, Thrombosis, Grown-up Congenital Heart Disease Councils: Cardiology Practice, Cardiovascular Imaging The content of these European Society of Cardiology (ESC) Guidelines has been published (...) . Management of associated conditions . . . . . . . . . . . .2459 3.5.1. Coronary artery disease . . . . . . . . . . . . . . . . . .2459 3.5.2. Arrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . .2459 4. Aortic regurgitation . . . . . . . . . . . . . . . . . . . . . . . . . . . .2460 4.1. Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2460 4.2. Natural history . . . . . . . . . . . . . . . . . . . . . . . . . . .2460 4.3. Results of surgery

2012 European Society of Cardiology

139. Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease

and 25mg. Changes visualized with the MIBG imaging technique will be correlated to the presence and severity of neurological (i.e. tremors, stiffness, slow movements, walking difficulties) and other symptoms associated with PD (i.e. abnormal smell, constipation, depression, color vision abnormalities), as measured by specific clinical scales and exams. Condition or disease Intervention/treatment Phase REM Sleep Behavior Disorder Pre-motor Parkinson Disease Symptomatic Parkinson Disease Drug: Carvedilol (...) Sponsor: Michele Tagliati, MD Information provided by (Responsible Party): Michele Tagliati, MD, Cedars-Sinai Medical Center Study Details Study Description Go to Brief Summary: REM Behavior Sleep Disorder (RBD) is a sleep disorder causing people to 'act out' their dreams. A high percentage of individuals with idiopathic RBD (iRBD) are known to develop conditions affecting the neurons in the brain such as Parkinson's disease (PD). Based on the increased risk to develop PD, individuals with iRBD

2018 Clinical Trials

140. NICOM in Pregnant Women With Heart Disease

using the NICOM against echocardiography for use in structurally normal and abnormal pregnant hearts in order to better drive goal-directed (specifically delivery mode) therapy through continuous hemodynamic monitoring during the second and third stages of labor, and 24 hours postpartum. Condition or disease Intervention/treatment Heart Diseases in Pregnancy Congenital Heart Disease in Pregnancy Diagnostic Test: NICOM (non-invasive cardiac output monitor) Study Design Go to Layout table for study (...) Years and older (Adult, Older Adult) Sexes Eligible for Study: Female Gender Based Eligibility: Yes Gender Eligibility Description: pregnant women. Accepts Healthy Volunteers: Yes Sampling Method: Non-Probability Sample Study Population Both healthy pregnant women and pregnant women with a history of heart disease will be recruited to participate in our observational, non-inferiority trial comparing the cardiac output measurements obtained by two different modalities. Women in their first trimester

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>